Valdecoxib is a selective cyclooxygenase-2 (COX-2) inhibitor belonging to the non-steroidal anti-inflammatory drug (NSAID) class, primarily utilized for the symptomatic treatment of osteoarthritis, rheumatoid… Read more



















Valdecoxib is a selective cyclooxygenase-2 (COX-2) inhibitor belonging to the non-steroidal anti-inflammatory drug (NSAID) class, primarily utilized for the symptomatic treatment of osteoarthritis, rheumatoid arthritis, and primary dysmenorrhea. Within the pharmaceutical industry, laboratory professionals utilize comprehensive reference standards of this compound, along with its associated impurities and metabolites, to facilitate rigorous analytical testing and quality control protocols. These materials are essential for impurity profiling, which ensures the safety and consistency of pharmaceutical formulations. Furthermore, stable isotope labelled versions of the drug and its related compounds serve as critical internal standards for accurate quantification in complex bioanalytical procedures, particularly those involving mass spectrometry. By providing reliable benchmarks for method validation and degradation studies, these reference materials support the maintenance of high analytical standards throughout drug development and manufacturing processes.